Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06544434

Laser Acupuncture for Meniere Disease

Laser Acupuncture for Meniere Disease: A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
324 (estimated)
Sponsor
Beijing Tongren Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Objective: To evaluate the effect of laser acupuncture for the patients Meniere disease. Methods: We enrolled 324 patients at Beijing Tongren Hospital. Patients completed outcome measures at baseline, 3 months, 6 months, and 12 months. Video head impulse test (vHIT), The Caloric Test, Tinnitus Handicap Inventory (THI), Dizziness Handicap Inventory (DHI), Pure Tone Audiometry (PTA), and visual scale of ear stuffiness to evaluate the therapeutic effects. A difference of P \< 0.05 was considered statistically significant.

Conditions

Interventions

TypeNameDescription
DEVICEMultiwave Locked System (MLS) laser (Mphi laser, ASA Srl, Vicenza, Italy)MLS laser is a class IV NIR laser with two synchronized sources (905 nm with 75 W peak power, pulsed mode; 808 nm with power 1 W, continuous mode). Both laser beams were synchronized, the locked waves work with the range 1-2000 Hz.
DRUGBetahistine Mesylate tabletBetahistine Mesylate tablet (Merislon, Eisai Co., Ltd., China) with the treatment of 6 mg, 3 times a day.

Timeline

Start date
2021-05-01
Primary completion
2024-09-30
Completion
2024-10-20
First posted
2024-08-09
Last updated
2024-08-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06544434. Inclusion in this directory is not an endorsement.